Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics save search
Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Published: 2023-02-06 (Crawled : 12:20) - biospace.com/
SAGE | $15.33 -0.71% -0.72% 850K
|
Health Technology
|
| O: 0.27%
H: 6.75%
C: 3.25%
BIIB | $196.76 -0.72% -0.72% 1.2M
|
Health Technology
|
| O: 0.51%
H: 2.52%
C: 1.12%
treatment fda drug application grants therapeutics review depression major depressive disorder
Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Published: 2023-02-06 (Crawled : 12:00) - globenewswire.com
SAGE | $15.33 -0.71% -0.72% 850K
|
Health Technology
|
| O: 0.27%
H: 6.75%
C: 3.25%
BIIB | $196.76 -0.72% -0.72% 1.2M
|
Health Technology
|
| O: 0.51%
H: 2.52%
C: 1.12%
treatment fda drug application grants therapeutics review depression major depressive disorder
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
Published: 2023-02-04 (Crawled : 08:20) - prnewswire.com
SDGR | $25.56 -3.37% -3.48% 710K
|
Technology Services
| Email alert
Add to watchlist
GPCR | $37.54 -4.53% -4.74% 400K
|
n/a
| Email alert
Add to watchlist
nasdaq therapeutics
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Published: 2023-02-03 (Crawled : 22:00) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
| Email alert
Add to watchlist
nasdaq grant therapeutics
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
TENX | $3.685 -2.0% -2.04% 34K
|
Health Technology
|
| O: -23.08%
H: 9.41%
C: 2.94%
offering therapeutics
PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation
Published: 2023-02-03 (Crawled : 13:20) - prnewswire.com
PTCT | $25.7 -2.73% -2.8% 960K
|
Health Technology
|
| O: -1.06%
H: 2.94%
C: 2.52%
award therapeutics innovation
Monte Rosa Therapeutics to Present at Upcoming Investor Conferences
Published: 2023-02-03 (Crawled : 13:00) - globenewswire.com
GLUE | $6.59 -8.6% -9.41% 120K
|
Professional, Scientific, and T...
|
| O: 0.28%
H: 18.88%
C: 14.83%
rosa therapeutics
Celldex Therapeutics Announces Upcoming Presentation of Barzolvolimab Phase 1b Results in Chronic Spontaneous Urticaria at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2023
Published: 2023-02-03 (Crawled : 12:20) - globenewswire.com
CLDX | $39.09 -0.41% -0.41% 410K
|
Health Technology
|
| O: -1.2%
H: 4.11%
C: 3.71%
immunology meeting urticaria therapeutics presentation results phase 2b
Structure Therapeutics Announces Pricing of Upsized Initial Public Offering
Published: 2023-02-03 (Crawled : 01:00) - globenewswire.com
GPCR | $37.54 -4.53% -4.74% 400K
|
n/a
| Email alert
Add to watchlist
offering therapeutics
PTC Therapeutics to Participate at Upcoming Investor Conference
Published: 2023-02-02 (Crawled : 22:00) - prnewswire.com
PTCT | $25.7 -2.73% -2.8% 960K
|
Health Technology
|
| O: -1.06%
H: 2.94%
C: 2.52%
conference therapeutics
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
Published: 2023-02-02 (Crawled : 22:00) - globenewswire.com
UTHR | $235.225 1.13% 1.12% 330K
|
Health Technology
|
| O: -0.1%
H: 1.37%
C: -2.48%
LQDA | $13.68 -1.93% -1.97% 610K
|
Health Technology
|
| O: 1.71%
H: 3.37%
C: 0.0%
patent trial therapeutics
Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
Published: 2023-02-02 (Crawled : 17:00) - biospace.com/
SAGE | $15.33 -0.71% -0.72% 850K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: -1.11%
report year therapeutics financial results
Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 15:20) - biospace.com/
CMPX | $1.56 -3.7% -3.85% 130K
|
Professional, Scientific, and T...
|
| O: 4.76%
H: 1.32%
C: -5.02%
biopharma global conference therapeutics
Gain Therapeutics to Participate in Upcoming Scientific and Medical ConferencesGain to present new preclinical data on its lead programs in GBA1-related diseases
Published: 2023-02-02 (Crawled : 15:00) - biospace.com/
GANX 4 | $3.055 -9.08% -9.98% 82K
|
Professional, Scientific, and T...
|
| O: 3.27%
H: 0.98%
C: -5.61%
preclinical medical therapeutics
Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360® CDx and Guardant360 Tissue
Published: 2023-02-02 (Crawled : 14:00) - biospace.com/
GH | $17.06 -8.67% -9.5% 2.4M
|
Health Services
|
| O: 3.0%
H: 4.19%
C: -1.76%
guardant360 collaboration health therapeutics
Repare Therapeutics to Participate in Two Upcoming Investor Conferences - February 2, 2023
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
RPTX 4 | $3.445 -5.62% -5.95% 90K
|
Health Technology
|
| O: 0.87%
H: 5.59%
C: 3.38%
therapeutics
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
XLO | $1.27 7.63% 7.09% 270K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 7.84%
C: 0.81%
day therapeutics
Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
RLAY | $6.82 -2.99% -3.08% 720K
|
Health Technology
|
| O: 2.58%
H: 4.23%
C: 2.34%
day therapeutics relay
Tango Therapeutics to Participate in Upcoming Investor Conferences - February 2, 2023
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
TNGX | $7.33 -0.41% -0.41% 320K
|
|
| O: 1.46%
H: 3.45%
C: 1.15%
therapeutics
Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for the Treatment of Solid Tumors
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
PLRX | $13.55 -4.24% -4.43% 270K
|
Health Technology
|
| O: 0.64%
H: 2.42%
C: -1.93%
pln-1010 treatment fda clearance drug therapeutics tumors
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.